secwatch.observer — SEC 8-K summary
======================================

Issuer:     Organogenesis Holdings Inc. (ORGO)
CIK:        0001661181
Form:       8-K
Filed at:   2022-05-05T23:59:59+00:00
Accession:  0001193125-22-142414
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Organogenesis appoints Michele Korfin and Gilberto Quintero to board as independent directors
--------------------------------------------------------------------------------

- Michele Korfin appointed as independent director; brings experience from Gamida Cell, Kite Pharma, Celgene.
- Gilberto Quintero appointed as independent director; serves as Chief Quality Officer at Kimberly-Clark, formerly at Cardinal Health.
- Each director receives $55,000 annual retainer and 23,913 RSUs vesting May 3, 2023.
- Board expands to 11 members, with majority now independent under Nasdaq standards.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661181/000119312522142414/0001193125-22-142414-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661181/000119312522142414/d716496d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-142414

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer